Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1988 1
1989 2
1990 2
1996 3
1998 6
1999 2
2000 4
2001 3
2002 4
2003 3
2004 2
2005 6
2006 7
2007 4
2008 3
2009 4
2010 2
2011 3
2012 5
2013 1
2014 6
2015 4
2016 1
2017 3
2018 6
2019 3
2020 2
2021 9
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

91 results
Results by year
Filters applied: . Clear all
Page 1
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, Deschênes G, Shasha-Lavsky H, Saland JM, Van't Hoff WG, Fuster DG, Magen D, Moochhala SH, Schalk G, Simkova E, Groothoff JW, Sas DJ, Meliambro KA, Lu J, Sweetser MT, Garg PP, Vaishnaw AK, Gansner JM, McGregor TL, Lieske JC; ILLUMINATE-A Collaborators. Garrelfs SF, et al. Among authors: frishberg y. N Engl J Med. 2021 Apr 1;384(13):1216-1226. doi: 10.1056/NEJMoa2021712. N Engl J Med. 2021. PMID: 33789010 Clinical Trial.
Novel therapeutic approaches for the primary hyperoxalurias.
Belostotsky R, Frishberg Y. Belostotsky R, et al. Among authors: frishberg y. Pediatr Nephrol. 2021 Sep;36(9):2593-2606. doi: 10.1007/s00467-020-04817-8. Epub 2020 Nov 6. Pediatr Nephrol. 2021. PMID: 33156410 Review.
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.
Frishberg Y, Deschênes G, Groothoff JW, Hulton SA, Magen D, Harambat J, Van't Hoff WG, Lorch U, Milliner DS, Lieske JC, Haslett P, Garg PP, Vaishnaw AK, Talamudupula S, Lu J, Habtemariam BA, Erbe DV, McGregor TL, Cochat P; study collaborators. Frishberg Y, et al. Clin J Am Soc Nephrol. 2021 Jul;16(7):1025-1036. doi: 10.2215/CJN.14730920. Epub 2021 May 13. Clin J Am Soc Nephrol. 2021. PMID: 33985991 Free PMC article. Clinical Trial.
Primary hyperoxalurias: diagnosis and treatment.
Ben-Shalom E, Frishberg Y. Ben-Shalom E, et al. Among authors: frishberg y. Pediatr Nephrol. 2015 Oct;30(10):1781-91. doi: 10.1007/s00467-014-3030-1. Epub 2014 Dec 18. Pediatr Nephrol. 2015. PMID: 25519509 Review.
Peritoneal dialysis for acute kidney injury.
Cullis B, Abdelraheem M, Abrahams G, Balbi A, Cruz DN, Frishberg Y, Koch V, McCulloch M, Numanoglu A, Nourse P, Pecoits-Filho R, Ponce D, Warady B, Yeates K, Finkelstein FO. Cullis B, et al. Among authors: frishberg y. Perit Dial Int. 2014 Jul-Aug;34(5):494-517. doi: 10.3747/pdi.2013.00222. Perit Dial Int. 2014. PMID: 25074995 Free PMC article. Review. No abstract available.
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children.
Sas DJ, Magen D, Hayes W, Shasha-Lavsky H, Michael M, Schulte I, Sellier-Leclerc AL, Lu J, Seddighzadeh A, Habtemariam B, McGregor TL, Fujita KP, Frishberg Y; ILLUMINATE-B Workgroup. Sas DJ, et al. Among authors: frishberg y. Genet Med. 2022 Mar;24(3):654-662. doi: 10.1016/j.gim.2021.10.024. Epub 2021 Dec 8. Genet Med. 2022. PMID: 34906487 Free article. Clinical Trial.
Benign plexus neuropathy in children.
Zeharia A, Mukamel M, Frishberg Y, Weitz R, Mimouni M. Zeharia A, et al. Among authors: frishberg y. J Pediatr. 1990 Feb;116(2):276-8. doi: 10.1016/s0022-3476(05)82890-2. J Pediatr. 1990. PMID: 2153791 Review. No abstract available.
Eosinophilia in a peritoneal dialysis patient: Questions.
Tzvi-Behr S, Frishberg Y, Ben-Shalom E, Rinat C, Becker-Cohen R. Tzvi-Behr S, et al. Among authors: frishberg y. Pediatr Nephrol. 2018 Sep;33(9):1505. doi: 10.1007/s00467-017-3845-7. Epub 2017 Nov 16. Pediatr Nephrol. 2018. PMID: 29147861 No abstract available.
91 results